For individuals facing Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a serious condition, the introduction of this treatment and the formulated version represents a genuine change. These groundbreaking therapies preserve the transthyretin protein, preventing its destructive build-up and alleviating the burden of the illness. Patients are now … Read More